Skip to content

NEXCORE HEALTHCARE CAPITAL CORP: 10-Q filed 2012-11-13

What NEXCORE HEALTHCARE CAPITAL CORP reported in its quarterly report filed 2012-11-13 (fiscal Q3 2012): 28 published measures, 81 facts as tagged in accession 0001233275-12-000011.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-13
Fiscal period
fiscal Q3 2012
Accession
0001233275-12-000011 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEXCORE HEALTHCARE CAPITAL CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-309,992,915USD
At 2011-12-3110,974,288USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-30794,750USD
At 2011-12-311,895,008USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-308,738,646USD
At 2011-12-318,671,693USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-303,172,077USD
At 2011-12-311,930,441USD
At 2011-09-301,371,280USD
At 2010-12-313,513,651USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,255,817USD92
2012-01-01 to 2012-09-30454,953USD274
2011-07-01 to 2011-09-30-461,613USD92
2011-01-01 to 2011-09-30-1,535,873USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30566,061USD274
2011-01-01 to 2011-09-30-2,124,049USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-07-01 to 2012-09-303,059,106USD92
2012-01-01 to 2012-09-306,028,758USD274
2011-07-01 to 2011-09-301,467,178USD92
2011-01-01 to 2011-09-304,175,187USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-9,974USD274
2011-01-01 to 2011-09-300USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30685,549USD274
2011-01-01 to 2011-09-30-18,322USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-30-2,059,705USD
At 2011-12-31-2,514,658USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-07-01 to 2012-09-3049,455,841shares92
2012-01-01 to 2012-09-3049,455,841shares274
2011-07-01 to 2011-09-3049,455,841shares92
2011-01-01 to 2011-09-3049,455,841shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-07-01 to 2012-09-3051,845,237shares92
2012-01-01 to 2012-09-3051,822,884shares274
2011-07-01 to 2011-09-3049,455,841shares92
2011-01-01 to 2011-09-3049,455,841shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-07-01 to 2012-09-300.03USD/shares92
2012-01-01 to 2012-09-300.01USD/shares274
2011-07-01 to 2011-09-30-0.01USD/shares92
2011-01-01 to 2011-09-30-0.03USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-07-01 to 2012-09-300.02USD/shares92
2012-01-01 to 2012-09-300.01USD/shares274
2011-07-01 to 2011-09-30-0.01USD/shares92
2011-01-01 to 2011-09-30-0.03USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-30506,958USD
At 2011-12-31585,175USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-07-01 to 2012-09-3033,849USD92
2012-01-01 to 2012-09-30101,477USD274
2011-07-01 to 2011-09-3026,032USD92
2011-01-01 to 2011-09-3069,304USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,063,118USD92
2012-01-01 to 2012-09-3052,461USD274
2011-07-01 to 2011-09-30-509,926USD92
2011-01-01 to 2011-09-30-1,684,258USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,995,988USD92
2012-01-01 to 2012-09-305,976,297USD274
2011-07-01 to 2011-09-301,977,104USD92
2011-01-01 to 2011-09-305,859,445USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,627,792USD92
2012-01-01 to 2012-09-305,030,770USD274
2011-07-01 to 2011-09-301,688,395USD92
2011-01-01 to 2011-09-305,182,202USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3049,455,841shares
At 2011-12-3149,455,841shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-09-30-489,477USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-09-309,198,165USD
At 2011-12-319,079,280USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-09-30551,620USD
At 2011-12-31443,694USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,399,135USD92
2012-01-01 to 2012-09-30516,859USD274
2011-07-01 to 2011-09-30-509,959USD92
2011-01-01 to 2011-09-30-1,695,957USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,130,827USD92
2012-01-01 to 2012-09-3027,382USD274
2011-07-01 to 2011-09-30-509,959USD92
2011-01-01 to 2011-09-30-1,695,957USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2011-01-01 to 2011-09-300USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2012-01-01 to 2012-09-300USD274
2011-01-01 to 2011-09-300USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30663,493USD274
2011-01-01 to 2011-09-30-398,714USD273

Inspect the source

Entity
NEXCORE HEALTHCARE CAPITAL CORP / CIK 0001233275
Captured
SEC response SHA-256
ddaa25a7006139c43ee19ed042e3e2814629891dd1a1cbfa26294179c47db398

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001233275.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))